Bausch + Lomb Corp
NYSE:BLCO

Watchlist Manager
Bausch + Lomb Corp Logo
Bausch + Lomb Corp
NYSE:BLCO
Watchlist
Price: 17.9 USD 1.42% Market Closed
Market Cap: 6.3B USD
Have any thoughts about
Bausch + Lomb Corp?
Write Note

Operating Margin
Bausch + Lomb Corp

4.1%
Current
5%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
4.1%
=
Operating Profit
190m
/
Revenue
4.7B

Operating Margin Across Competitors

Country CA
Market Cap 6.3B USD
Operating Margin
4%
Country JP
Market Cap 7T JPY
Operating Margin
28%
Country CH
Market Cap 38.2B CHF
Operating Margin
13%
Country DK
Market Cap 177.1B DKK
Operating Margin
27%
Country US
Market Cap 16.3B USD
Operating Margin
17%
Country KR
Market Cap 10.3T KRW
Operating Margin
-245%
Country CN
Market Cap 51B CNY
Operating Margin
45%
Country US
Market Cap 6.7B USD
Operating Margin
32%
Country UK
Market Cap 4.6B GBP
Operating Margin
13%
Country US
Market Cap 5.6B USD
Operating Margin
12%
Country CH
Market Cap 4.7B CHF
Operating Margin
14%
No Stocks Found

Bausch + Lomb Corp
Glance View

Market Cap
6.3B USD
Industry
Health Care

Founded in 1853, Bausch + Lomb Corp. began as a small optical goods store in Rochester, New York, eventually blossoming into a multinational eye health business. Over its long history, the company has established itself as a cornerstone in the realm of vision care, leveraging its deep expertise to innovate and expand its product offerings. Today, Bausch + Lomb operates through three primary business segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. In the Vision Care segment, it provides contact lenses, lens care products, and other related items, making it a trusted choice for consumers around the globe. The Ophthalmic Pharmaceuticals division addresses a broad spectrum of eye health needs, producing prescription and over-the-counter pharmaceuticals that target various eye conditions. Meanwhile, the Surgical segment offers a suite of ophthalmic surgical devices, designed for procedures ranging from cataract extraction to vitreoretinal surgery. Bausch + Lomb generates revenue through a mix of consumer products and medical equipment. Their extensive contact lens product line caters to diverse needs – from daily disposables to specialized lenses for specific eye conditions, thereby capturing a significant portion of the eye care market. The company's pharmaceuticals and surgical tools not only complement its vision care products but also tap into the lucrative medical market, providing solutions for both medical professionals and their patients. By maintaining a robust portfolio that spans consumer goods and professional-grade equipment, Bausch + Lomb effectively positions itself as both a retail and medical partner, ensuring steady revenue streams from a global customer base. With a blend of research-driven innovation and strategic market positioning, Bausch + Lomb continues to cement its legacy as a leader in eye health.

BLCO Intrinsic Value
26.87 USD
Undervaluation 33%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
4.1%
=
Operating Profit
190m
/
Revenue
4.7B
What is the Operating Margin of Bausch + Lomb Corp?

Based on Bausch + Lomb Corp's most recent financial statements, the company has Operating Margin of 4.1%.